Skip to main content
. 2017 Jul 19;7:211–215. doi: 10.1016/j.pmedr.2017.07.004

Table 2.

Prevalence of metabolic syndrome and metabolic syndrome components in 26,609 young adults.

Author Country Total (n) MetSyn WC HDL TG BP FBG
Harmonized Al Dhaheri et al. (2016) UAE 555 38 (6.8) 101 (18.2) 271 (48.8) 8 (1.4) 30 (5.4) 54 (9.7)
Bennett et al. (2014) Jamaica 746 6 (0.8) 108 (14.5) 343 (46.0) 4 (0.5) 154 (20.6) 8 (1.1)
Ferguson et al. (2010) Jamaica 839 10 (1.2) 134 (16.0) 393 (46.8) 5 (0.6) 56 (6.7) 10 (1.2)
Gavrila et al. (2011)a Spain 292 18 (6.2) 81 (27.7) 49 (16.8) 24 (8.2) 48 (16.4) 11 (3.8)
Gupta et al. (2009) India 486 12(2.5) 51 (10.5) 150 (30.9) 27 (5.6) 15 (3.1) 31 (6.4)
Huang et al. (2015) Taiwan 355 24 (6.8) 63 (17.7) 46 (20.6) 32 (9.0) 123 (34.6) 4 (1.1)
Kaduka et al. (2012) Kenya 90 9 (10.0) 17 (18.9) 47 (52.2) 3 (3.3) 51 (56.7) 1 (1.1)
Lin et al. (2014) China 323 22 (6.8) 180 (55.7) 63 (19.5) 40 (12.4) 20 (6.2) 22 (6.8)
Martins et al. (2015)a Brazil 2031 242 (9.0) 646 (31.8) 851 (41.9) 254 (12.5) 465 (22.9) 73 (3.6)
Sy et al. (2014)a Philippines 861 108 (12.5) 173 (20.1) 467 (54.2) 171 (19.9) 127 (14.8) 144 (16.7)
Overall 6578 430 (6.5%) 1554 (23.6%) 2707 (41.2%) 568 (8.6%) 1089 (16.6%) 358 (5.4%)
NCEP –ATPIII Erem et al. (2008) Turkey 1306 93 (7.1) 182 (13.9) 318 (21.3) 183 (14.0) 424 (32.5) 25 (1.9)
Gündogan et al. (2009)a Turkey 84 10 (11.9) 25 (29.8) 19 (22.6) 24 (28.6) 20 (23.8) 11 (13.1)
Huang et al. (2004) USA 163 1 (0.6) 3 (1.8) 22 (13.5) 4 (2.5) 2 (1.2) 3 (1.8)
Li et al. (2010)a China 2532 101 (4.0) 79 (3.1) 742 (29.3) 241 (9.5) 519 (20.5) 58 (2.3)
Manjunath et al. (2014) India 473 41 (8.7) 76 (16.1) 184 (38.9) 37 (7.8) 123 (26.0) 42 (8.9)
Mikkola et al. (2007)a Finland 1099 38 (3.5) 51 (4.6) 212 (19.3) 31 (2.8) 565 (51.4) 25 (2.3)
Sidorenkov et al. (2010) Russia 862 23 (2.7) 19 (2.2) 266 (30.9) 83 (9.6) 149 (17.3) 6 (0.7)
Sinha et al. (2013) India 85 8 (9.4) 18 (21.2) 53 (62.4) 18 (21.2) 5 (5.9) 7 (8.2)
Soysal et al. (2005) Turkey 285 18 (6.3) 14 (4.9) 40 (14.0) 115 (40.4) 25 (8.8) 13 (4.6)
Overall 6889 333 (4.8%) 467 (6.8%) 1856 (26.9%) 736 (10.7%) 1832 (26.6%) 190 (2.8%)
IDF Bener et al. (2009)a Qatar 203 16 (7.9) 16 (7.9) 43 (21.2) 30 (14.8) 34 (16.7) 8 (3.9)
da Costa et al. (2011) Brazil 711 28 (3.9) 90 (12.7) 313 (44.0) 35 (4.9) 71 (10.0) 35 (1.4)
da Silveira et al. (2010)a Brazil 3599 240 (6.7) 618 (17.2) 694 (19.3) 598 (16.6) 883 (24.5) 1322 (36.7)
Gavrila et al. (2011)a Spain 292 18 (6.2) 81 (27.7) 49 (16.8) 24 (8.2) 48 (16.4) 11 (3.8)
Gündogan et al. (2009)a Turkey 84 16 (19.0) 25 (29.8) 19 (22.6) 24 (28.6) 20 (23.8) 11 (13.1)
Hildrum et al. (2007)a Norway 1615 19 (1.2) 414 (25.6) 459 (28.4) 221 (13.7) 499 (30.9) 179 (11.1)
Huang et al. (2007)a USA 300 2 (0.7) 8 (2.7) 73 (24.3) 27 (9.0) 11 (3.7) 27 (9.0)
Kanitkar et al. (2015) India 250 55 (22.0) 139 (55.6) 93 (37.2) 71 (29.2) 21 (8.4) 44 (17.6)
Li et al. (2010)a China 2532 147 (5.8) 79 (3.1) 742 (29.3) 241 (9.5) 519 (20.5) 58 (2.3)
Martins et al. (2015)a Brazil 2031 242 (11.9) 646 (31.8) 851 (41.9) 254 (12.5) 465 (22.9) 73 (3.6)
Mikkola et al. (2007)a Finland 1099 75 (6.8) 134 (12.2) 212 (19.3) 31 (2.8) 565 (51.4) 221 (20.1)
Sy et al. (2014)a Philippines 861 108 (9.1) 173 (20.1) 467 (54.2) 171 (19.9) 127 (14.8) 144 (16.7)
Tope et al. (2013)a USA 376 35 (9.3) 43 (11.4) 73 (19.4) 21 (5.6) 38 (10.1) 42(11.2)
Overall 13,953 971 (7.0%) 2466 (17.7%) 4088 (29.3%) 1750 (12.5%) 3301 (23.7%) 2150 (15.4%)
AHA/NHBLI Bener et al. (2009)a Qatar 203 15 (7.4) 16 (7.9) 43 (21.2) 30 (14.8) 34 (16.7) 8 (3.9)
Cheserek et al. (2014) China 200 1 (0.5) 4 (2.0) 19 (9.5) 13 (6.5) 24 (12.0) 6 (3.0)
da Silveira et al. (2010)a Brazil 3599 213 (5.9) 269 (7.5) 694 (19.3) 598 (16.6) 883 (24.5) 610 (16.9)
Dalleck and Kjelland (2012) USA 207 14 (6.8) 12 (5.8) 98 (47.3) 28 (13.5) 34 (16.4) 15 (7.2)
de Kroon et al. (2008) Netherlands 642 48 (7.5) 78 (12.1) 187 (29.1) 50 (7.8) 274 (42.7) 75 (11.7)
Fernandes and Lofgren (2011) USA 189 7 (3.7) 14 (7.4) 38 (20.1) 33 (17.5) 4 (2.1) 14 (7.4)
Gavrila et al. (2011)a Spain 292 10 (3.4) 31 (10.6) 49 (16.8) 24 (8.2) 48 (16.4) 11 (3.8)
Hildrum et al. (2007)a Norway 1615 19 (1.2) 414 (25.6) 459 (28.4) 221 (13.7) 499 (30.9) 179 (11.1)
Huang et al. (2007)a USA 300 4 (1.3) 8 (2.7) 73 (24.3) 27 (9.0) 11 (3.7) 27 (9.0)
Morrell et al. (2013) USA 1610 81 (5.0) 209 (130) 467 (29.0) 258 (16.0) 403 (25.0) 64 (4.0)
Morrell et al. (2012) USA 2103 103 (4.9) 94 (4.5) 538 (25.6) 350 (16.6) 681 (32.4) 177 (8.4)
Shahbazian et al. (2013) Iran 203 13 (6.4) 26 (12.8) 85 (41.9) 47 (23.2) 1 (0.5) 35 (17.2)
Sharifi et al. (2009) Iran 934 70 (7.5) 31 (9.7) 714 (76.4) 246 (26.3) 56 (6.0) 74 (7.9)
Tope et al. (2013)a USA 376 45 (12.0) 43 (11.4) 73 (19.4) 21 (5.6) 38 (10.1) 42 (11.2)
Overall 12,473 643 (5.2%) 1309 (10.5%) 3537 (28.4%) 1946 (15.6%) 2990 (24.0%) 1337 (10.7%)

Data are expressed as n (%).

MetSyn – metabolic syndrome; WC – abdominal obesity; HDL - atherogenic dyslipidaemia (low HDL); TG - atherogenic dyslipidaemia (raised triglycerides); BP - raised blood pressure; FBG – raised fasting glucose.

a

Indicates study used more than one definition of MetSyn and is included multiple times.